 Myovant Sciences Ltd. NYSE:MYOV Q1 2022 Results Conference Call July 27, 2022 5:00 PM ET Company Participants Uneek Mehra - Chief Financial Business Officer Dave Marek - Chief Executive Officer Lauren Merendino - Chief Commercial Officer Dr. Juan Camilo Arjona - Chief Medical Officer Conference Call Participants Phil Nadeau - Cowen Brian Skorney - Baird Eric Joseph - JPMorgan Madhu Kumar - Goldman Sachs Roanna Ruiz - SVB Securities Gavin Clark-Gartner - Evercore ISI Operator Good day, everyone and welcome to Myovant Sciences First Quarter Fiscal Year 2022 Earnings Conference Call. 